Stevens-Johnson syndrome after treatment with bendamustine
2012; Elsevier BV; Volume: 36; Issue: 7 Linguagem: Inglês
10.1016/j.leukres.2012.03.006
ISSN1873-5835
AutoresMatteo Lambertini, Lucia Del Mastro, G. Gardin, Alessia Levaggi, Claudia Bighin, S. Giraudi, P. Pronzato,
Tópico(s)Lymphoma Diagnosis and Treatment
ResumoDrug reactions resulting from chemotherapy agents are common and frequently affect the skin. Although often benign, a select few of these cutaneous reactions may necessitate immediate changes to the antineoplastic regimens. Given the diversity of chemotherapeutic skin reactions and their complex implications on patient management, an organized conceptual schema is imperative for proper patient care. We evaluate a number of commonly seen chemotherapy-induced skin toxicities organized by pathogenic mechanism and drug class, providing a framework for the identification and categorization of adverse events to prevent unrecognition. Groupings of these reactions include direct cytotoxicity and/or drug accumulation, immunologic hypersensitivity, and aberrant molecular signaling.
Referência(s)